Dr Taylor is associate professor of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania, and attending physician, St. Christopher’s Hospital for Children, Philadelphia.

This episode bridges the gap between clinical trial data and everyday practice, focusing on how pediatricians can systematically ensure no eligible infant falls through the cracks. This episode ...

The July 1, 2026 decision makes exagamglogene autotemcel the first gene therapy approved for SCD in children younger than 12 years. The FDA has issued a supplemental approval for Casgevy ...

The AAP now recommends universal iron deficiency screening for all infants between 9 and 18 months and for all adolescents at least 1 year after menarche but no later than age 14. Updated ferritin ...

Higher vaccination rates could significantly reduce disease burden: Increasing pediatric influenza immunization to 70% may prevent millions of outpatient visits, tens of thousands of hospitalizations, ...

Infant formula safety reaffirmed: Most samples had undetectable or very low contaminant levels, supporting the safety of the US formula supply. Contaminants detected at very low levels: When present, ...

New evidence using sibling-matched analyses suggests no meaningful association between prenatal acetaminophen use and autism. In this interview, Kira Philipsen Prahm, MD, PhD, a medical doctor at ...

The American Academy of Dermatology has released its first pediatric-specific atopic dermatitis guidelines, addressing key differences in safety, dosing, and care delivery for children. Evidence for ...

Cognitive-linguistic deficits in kindergarten—especially in phonological awareness and letter knowledge—strongly predict early-emerging dyslexia by first grade. Specific kindergarten deficits, ...

The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment. In a recent discussion with ...

Intravenous gadopiclenol (Vueway; Bracco) is now approved for use in infants and neonates, extending its indication to the youngest patient populations. Gadopiclenol provides high-quality contrast ...

Early intervention services before aged 3 years were associated with greater odds of meeting third-grade math and English language arts standards. Academic benefits were most pronounced among children ...